The U.S. State Department is advising Americans to avoid 80% of the world’s coronavirus epidemics.
In a note to the media about his updated travel directions, it said the epidemic continues to pose an “unprecedented risk for travelers.”
The current U.S. “Do Not Travel” consultant covers 34 of the 200 countries.
Covid-19 now claims the lives of more than three million people worldwide – more than half a million in the United States.
The World Health Organization (WHO) has warned the world that it is “approaching the highest rate of infection” despite its global role in the global vaccination program.
The State Department said the decision to update its travel adviser was in line with those received from the Centers for Disease Control and Prevention (CDC) and “does not mean a reassessment of the current health situation in a given country.”
However, it said the move would “increase the number of Level 4 countries: do not travel, in about 80% of the world’s countries”.
Only three places in the world have the lowest assessment among the four risk levels of the state department – “practice general caution”. They are Macau, Taiwan, and New Zealand.
Even Antarctica is in the second tier – “caution by increasing practice” – while the United Kingdom is in the third tier – “reconsideration trip” – with extra caution for caution due to the risk of terrorism.
The CDC currently advises all Americans to refrain from traveling domestically until they are fully vaccinated and warns that international travel also poses an “additional risk” for vaccinators.
Although more than 860 million doses of the coronavirus vaccine have been given in 165 countries worldwide, many countries are still struggling with the virus.
Brazil recorded the third-highest number of cases and 368,749, the second-highest number of deaths in the world.
Canada has also reported the rise in recent cases, and Papua New Guinea has been cited as a cause for concern.
While some countries – such as Israel and the United Kingdom – have protected and supplied a large portion of their population, many more are still waiting for the arrival of their first shipments.
This leads to caution about increasing “vaccine inequality” – jobs are not being shared fairly between rich and poor countries.